Avoid common mistakes on your manuscript.
Erratum to: J Gastroenterol DOI 10.1007/s00535-017-1348-8
The errors in the publication of the original article have been updated and the details are given below for your reading:
An article note “Kazuhiko Masuda and Atsushi Ono are the co-first authors” should be included.
The second sentence in the subheading “Results” under the “Abstract” section should read as “High HMGB1 at 4 weeks (P = 0.025), vascular invasion to the hepatic vein (Vv) (P = 0.009), mRECIST (P < 0.0001) and Child–Pugh B (P = 0.004) were identified as independent predictors of poor overall survival in HAIC treatment.”
The original article was corrected.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Kazuhiko Masuda and Atsushi Ono are the co-first authors.
The online version of the original article can be found under doi:10.1007/s00535-017-1348-8.
Rights and permissions
About this article
Cite this article
Masuda, K., Ono, A., Aikata, H. et al. Erratum to: Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy. J Gastroenterol 53, 161–162 (2018). https://doi.org/10.1007/s00535-017-1352-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00535-017-1352-z